@TonyWAIW At the moment I don't see the disadvantage in holding onto the cash Tony. Very rarely is a debt-free Aussie biotech that is going through a growth stage in a position to expand that growth through self funded means. I would understand your argument if Neuren proposed to hold onto the cash for an extended period rotting in a bank account at the expense of further growth (looking at you Clinuvel), but thats not the impression I get with Jon and Co.
If Neuren decide to keep the four NNZ2591 indications, they won't have the resources to fully develop them so incurring debt will be a part of the mix no doubt. But fiscal propriety is still important in how the market views Neuren and its operations. I say having a significant war chest as Neuren has would stabilise the sp, keep Neuren independent through the NNZ-2591 development stage, or ultimately increase Neuren's leverage in asking for a higher takeover price. "We can fund ourselves with cash and debt, if you want us you'll have to pay through the nose".
- Forums
- ASX - By Stock
- NEU
- Share Price
Share Price, page-6160
-
- There are more pages in this discussion • 4,642 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NEU (ASX) to my watchlist
(20min delay)
|
|||||
Last
$20.02 |
Change
0.120(0.60%) |
Mkt cap ! $2.543B |
Open | High | Low | Value | Volume |
$20.22 | $20.44 | $20.02 | $841.6K | 41.60K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 339 | $20.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$20.03 | 216 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 177 | 20.080 |
5 | 356 | 20.070 |
4 | 245 | 20.060 |
3 | 239 | 20.050 |
6 | 783 | 20.040 |
Price($) | Vol. | No. |
---|---|---|
20.110 | 76 | 4 |
20.120 | 273 | 5 |
20.130 | 279 | 4 |
20.140 | 404 | 6 |
20.150 | 354 | 6 |
Last trade - 12.04pm 04/07/2024 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham, CEO
James Graham
CEO
Previous Video
Next Video
SPONSORED BY The Market Online